GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
23.98
+1.19 (5.22%)
Dec 15, 2025, 4:00 PM EST
GSK plc Market Cap
GSK plc has a market cap or net worth of $98.09 billion as of December 16, 2025. Its market cap has increased by 39.53% in one year.
Market Cap
98.09B
Enterprise Value
116.95B
Revenue
43.24B
Ranking
n/a
PE Ratio
13.28
Stock Price
$23.98
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 96.45B to 98.09B, an increase of 1.70%. That is a compound annual growth rate of 0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 98.09B | 42.60% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | 91.20B | -21.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 291.10M |